GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dianthus Therapeutics Inc (NAS:DNTH) » Definitions » FCF Yield %

Dianthus Therapeutics (Dianthus Therapeutics) FCF Yield % : -3.49 (As of May. 16, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Dianthus Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Dianthus Therapeutics's Trailing 12-Month Free Cash Flow is $-26.84 Mil, and Market Cap is $768.07 Mil. Therefore, Dianthus Therapeutics's FCF Yield % for today is -3.49%.

The historical rank and industry rank for Dianthus Therapeutics's FCF Yield % or its related term are showing as below:

DNTH' s FCF Yield % Range Over the Past 10 Years
Min: -67.89   Med: -10.15   Max: -3.24
Current: -3.49


During the past 3 years, the highest FCF Yield % of Dianthus Therapeutics was -3.24%. The lowest was -67.89%. And the median was -10.15%.

DNTH's FCF Yield % is ranked better than
76.16% of 1556 companies
in the Biotechnology industry
Industry Median: -14.305 vs DNTH: -3.49

Dianthus Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was -1,713.16%.


Dianthus Therapeutics FCF Yield % Historical Data

The historical data trend for Dianthus Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dianthus Therapeutics FCF Yield % Chart

Dianthus Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -23.99

Dianthus Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial - - - -30.79 -6.80

Competitive Comparison of Dianthus Therapeutics's FCF Yield %

For the Biotechnology subindustry, Dianthus Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dianthus Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dianthus Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Dianthus Therapeutics's FCF Yield % falls into.



Dianthus Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Dianthus Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-36.971 / 154.10408
=-23.99%

Dianthus Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.973 * 4 / 880.458
=-6.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dianthus Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Dianthus Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Dianthus Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dianthus Therapeutics (Dianthus Therapeutics) Business Description

Traded in Other Exchanges
Address
7 Times Square, 43rd Floor, New York, NY, USA, 10036
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is comprised of an experienced team of biotech and pharma executives who are leading the next generation of antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune diseases.

Dianthus Therapeutics (Dianthus Therapeutics) Headlines